193 related articles for article (PubMed ID: 29472932)
1.
Flores-Santibáñez F; Cuadra B; Fernández D; Rosemblatt MV; Núñez S; Cruz P; Gálvez-Cancino F; Cárdenas JC; Lladser A; Rosemblatt M; Bono MR; Sauma D
Front Immunol; 2018; 9():209. PubMed ID: 29472932
[TBL] [Abstract][Full Text] [Related]
2. IL-17/IFN-γ double producing CD8+ T (Tc17/IFN-γ) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12.
Tajima M; Wakita D; Satoh T; Kitamura H; Nishimura T
Int Immunol; 2011 Dec; 23(12):751-9. PubMed ID: 22039016
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of tumor-reactive type 1 and type 2 CD8+ T cell subpopulations in established pulmonary metastases.
Dobrzanski MJ; Reome JB; Dutton RW
J Immunol; 1999 Jun; 162(11):6671-80. PubMed ID: 10352285
[TBL] [Abstract][Full Text] [Related]
4. Antifungal Tc17 cells are durable and stable, persisting as long-lasting vaccine memory without plasticity towards IFNγ cells.
Nanjappa SG; McDermott AJ; Fites JS; Galles K; Wüthrich M; Deepe GS; Klein BS
PLoS Pathog; 2017 May; 13(5):e1006356. PubMed ID: 28542595
[TBL] [Abstract][Full Text] [Related]
5. Adoptive transfer of tumor-specific Tc17 effector T cells controls the growth of B16 melanoma in mice.
Garcia-Hernandez Mde L; Hamada H; Reome JB; Misra SK; Tighe MP; Dutton RW
J Immunol; 2010 Apr; 184(8):4215-27. PubMed ID: 20237297
[TBL] [Abstract][Full Text] [Related]
6. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge.
Hamada H; Garcia-Hernandez Mde L; Reome JB; Misra SK; Strutt TM; McKinstry KK; Cooper AM; Swain SL; Dutton RW
J Immunol; 2009 Mar; 182(6):3469-81. PubMed ID: 19265125
[TBL] [Abstract][Full Text] [Related]
7. IFN-γ- and IL-17-producing CD8
Ohkuri T; Kosaka A; Ikeura M; Salazar AM; Okada H
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34193567
[TBL] [Abstract][Full Text] [Related]
8. Adoptive transfer of Tc1 or Tc17 cells elicits antitumor immunity against established melanoma through distinct mechanisms.
Yu Y; Cho HI; Wang D; Kaosaard K; Anasetti C; Celis E; Yu XZ
J Immunol; 2013 Feb; 190(4):1873-81. PubMed ID: 23315072
[TBL] [Abstract][Full Text] [Related]
9. RORγ Agonists Enhance the Sustained Antitumor Activity through Intrinsic Tc17 Cytotoxicity and Tc1 Recruitment.
Liu X; Zawidzka EM; Li H; Lesch CA; Dunbar J; Bousley D; Zou W; Hu X; Carter LL
Cancer Immunol Res; 2019 Jul; 7(7):1054-1063. PubMed ID: 31064778
[TBL] [Abstract][Full Text] [Related]
10. Increased IL-17 and/or IFN-γ producing T-cell subsets in gut mucosa of long-term-treated HIV-1-infected women.
d'Ettorre G; Borrazzo C; Pinacchio C; Santinelli L; Cavallari EN; Statzu M; Fanello G; Ceccarelli G; Antonelli G; Vullo V; Mastroianni CM; Scagnolari C
AIDS; 2019 Mar; 33(4):627-636. PubMed ID: 30608274
[TBL] [Abstract][Full Text] [Related]
11. IL-17 and IL-4 producing CD8+ T cells in tumor draining lymph nodes of breast cancer patients: positive association with tumor progression.
Faghih Z; Rezaeifard S; Safaei A; Ghaderi A; Erfani N
Iran J Immunol; 2013 Dec; 10(4):193-204. PubMed ID: 24375061
[TBL] [Abstract][Full Text] [Related]
12. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
13. Tc17 CD8 T cells: functional plasticity and subset diversity.
Yen HR; Harris TJ; Wada S; Grosso JF; Getnet D; Goldberg MV; Liang KL; Bruno TC; Pyle KJ; Chan SL; Anders RA; Trimble CL; Adler AJ; Lin TY; Pardoll DM; Huang CT; Drake CG
J Immunol; 2009 Dec; 183(11):7161-8. PubMed ID: 19917680
[TBL] [Abstract][Full Text] [Related]
14. The inducible costimulator augments Tc17 cell responses to self and tumor tissue.
Nelson MH; Kundimi S; Bowers JS; Rogers CE; Huff LW; Schwartz KM; Thyagarajan K; Little EC; Mehrotra S; Cole DJ; Rubinstein MP; Paulos CM
J Immunol; 2015 Feb; 194(4):1737-47. PubMed ID: 25576595
[TBL] [Abstract][Full Text] [Related]
15. TGF-β and IL-21 cooperatively stimulate activated CD8(+) T cells to differentiate into Tc17 cells.
Chen HW; Tsai JP; Yao TY; Hsieh CL; Chen IH; Liu SJ
Immunol Lett; 2016 Jun; 174():23-7. PubMed ID: 27085379
[TBL] [Abstract][Full Text] [Related]
16. PD-1 limits differentiation and plasticity of Tc17 cells.
Arra A; Lingel H; Pierau M; Brunner-Weinzierl MC
Front Immunol; 2023; 14():1104730. PubMed ID: 37205114
[TBL] [Abstract][Full Text] [Related]
17. CD73-mediated adenosine production promotes stem cell-like properties in mouse Tc17 cells.
Flores-Santibáñez F; Fernández D; Meza D; Tejón G; Vargas L; Varela-Nallar L; Arredondo S; Guixé V; Rosemblatt M; Bono MR; Sauma D
Immunology; 2015 Dec; 146(4):582-94. PubMed ID: 26331349
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Accumulation of T Cytotoxic 1, T Cytotoxic 17, and T Cytotoxic 17/1 Cells in the Brain Contributes to Microglia-Mediated Chronic Neuroinflammation After Ischemic Stroke.
Shu L; Xu H; Ji J; Xu Y; Dong Z; Wu Y; Guo Y
Neuromolecular Med; 2024 Apr; 26(1):17. PubMed ID: 38684592
[TBL] [Abstract][Full Text] [Related]
19. CD4+ Th1 cells promote CD8+ Tc1 cell survival, memory response, tumor localization and therapy by targeted delivery of interleukin 2 via acquired pMHC I complexes.
Huang H; Hao S; Li F; Ye Z; Yang J; Xiang J
Immunology; 2007 Feb; 120(2):148-59. PubMed ID: 17274112
[TBL] [Abstract][Full Text] [Related]
20. Dynamic regulation of effector IFN-γ-producing and IL-17-producing T cell subsets in the development of acute graft-versus-host disease.
Zhao K; Ruan S; Yin L; Zhao D; Chen C; Pan B; Zeng L; Li Z; Xu K
Mol Med Rep; 2016 Feb; 13(2):1395-403. PubMed ID: 26647759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
